In Tyrosinemia Type II, deficiency of which enzyme?

Prepare for the Clinical Chemistry Numericals Test. Study with comprehensive questions, each with detailed explanations. Boost your confidence and excel on your exam!

Multiple Choice

In Tyrosinemia Type II, deficiency of which enzyme?

Explanation:
Tyrosinemia Type II results from a deficiency of tyrosine aminotransferase, the liver enzyme that normally converts tyrosine to p-hydroxyphenylpyruvate in tyrosine degradation. Without this step, tyrosine accumulates in blood and tissues, leading to ocular and skin changes such as corneal lesions and hyperkeratotic plaques on the hands and feet. The other enzymes listed are linked to different conditions: fumarylacetoacetate hydrolase deficiency causes Tyrosinemia Type I with severe liver involvement; tyrosine hydroxylase deficiency affects catecholamine synthesis; homogentisate oxidase deficiency causes alkaptonuria.

Tyrosinemia Type II results from a deficiency of tyrosine aminotransferase, the liver enzyme that normally converts tyrosine to p-hydroxyphenylpyruvate in tyrosine degradation. Without this step, tyrosine accumulates in blood and tissues, leading to ocular and skin changes such as corneal lesions and hyperkeratotic plaques on the hands and feet. The other enzymes listed are linked to different conditions: fumarylacetoacetate hydrolase deficiency causes Tyrosinemia Type I with severe liver involvement; tyrosine hydroxylase deficiency affects catecholamine synthesis; homogentisate oxidase deficiency causes alkaptonuria.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy